Status:
UNKNOWN
GDF 15 in Sickle Cell Disease and Hereditary Spherocytosis
Lead Sponsor:
Wolfson Medical Center
Conditions:
Patients With Thalassemia Intermedia,
Congenital Dyserythropoietic Anemia Type I
Eligibility:
All Genders
5+ years
Brief Summary
Patients with thalassemia intermedia, congenital dyserythropoietic anemia type I , and sideroblastic anemia were found to express very high levels of serum GDF15, and this contributed to the inappropr...
Detailed Description
The identification of the ferroportin/hepcidin axis has allowed the effect of erythroid activity on iron balance to be studied and has created the basis for better defining the erythroid regulators. ...
Eligibility Criteria
Inclusion
- non
Exclusion
- non
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01201135
Start Date
September 1 2010
End Date
September 1 2011
Last Update
September 14 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.